• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管生成性低氧细胞毒素三嗪 - N - 氧化物衍生物的设计、合成及生物活性

Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives.

作者信息

Nagasawa Hideko, Yamashita Mao, Mikamo Naoko, Shimamura Mariko, Oka Shigenori, Uto Yoshihiro, Hori Hitoshi

机构信息

Department of Biological Science and Technology, Faculty of Engineering, The University of Tokushima, Minamijosanjima-cho 2-1, Tokushima 770-8506, Japan.

出版信息

Comp Biochem Physiol A Mol Integr Physiol. 2002 May;132(1):33-40. doi: 10.1016/s1095-6433(01)00526-8.

DOI:10.1016/s1095-6433(01)00526-8
PMID:12062188
Abstract

For cancer therapy, hypoxia represents an important tumor specific target. Therefore we designed and synthesized antiangiogenic hypoxic cytotoxins as 'hypoxia modifiers'. They can be activated bioreductively in hypoxic cells to kill the oxygen-deficient tumor cells selectively and prevent their re-growth. The aromatic heterocycle di-N-oxides, tirapazamine (TPZ), TX-1102, and TX-402 inhibited growth of EMT6/KU cells, SAS/neo cells, and SAS/Trp248 cells (mutant p53 gene transformant) under hypoxic condition. They also induced apoptosis selectively at a dose of 10 microM each under hypoxic condition for 5 h. Their hypoxic cytotoxicities and apoptosis inducing activities were p53-independent because the activities in SAS/neo cells were almost similar to that in SAS/Trp248 cells. In angiogenesis inhibition assay using chick embryo chorioallantoic membrane (CAM), TPZ, TX-1102, TX-402 and TX-1033 showed 40, 25, 60 and 60% inhibition of angiogenesis each at a dose of 10 microg/CAM. On the other hand, the nitrosopyrimidine, TX-1041 had neither antiangiogenic activity nor cytotoxicity. Therefore the di-N-oxide group is thought to be required for the biological activities. TX-1102 was a potent antiangiogenic hypoxic cytotoxin inducing apoptosis p53-independently.

摘要

对于癌症治疗而言,缺氧是一个重要的肿瘤特异性靶点。因此,我们设计并合成了抗血管生成的缺氧细胞毒素作为“缺氧调节剂”。它们可在缺氧细胞中通过生物还原作用被激活,从而选择性地杀死缺氧的肿瘤细胞,并阻止其再次生长。芳香族杂环二氮氧化物替拉扎明(TPZ)、TX - 1102和TX - 402在缺氧条件下抑制了EMT6/KU细胞、SAS/neo细胞和SAS/Trp248细胞(突变型p53基因转化体)的生长。在缺氧条件下处理5小时,它们各自在10微摩尔的剂量下还能选择性地诱导细胞凋亡。它们的缺氧细胞毒性和诱导凋亡活性与p53无关,因为SAS/neo细胞中的活性与SAS/Trp248细胞中的活性几乎相似。在使用鸡胚绒毛尿囊膜(CAM)的血管生成抑制试验中,TPZ、TX - 1102、TX - 402和TX - 1033在10微克/CAM的剂量下分别显示出40%、25%、60%和60%的血管生成抑制率。另一方面,亚硝基嘧啶TX - 1041既没有抗血管生成活性也没有细胞毒性。因此,二氮氧化物基团被认为是这些生物活性所必需的。TX - 1102是一种强效的抗血管生成缺氧细胞毒素,可独立于p53诱导细胞凋亡。

相似文献

1
Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives.抗血管生成性低氧细胞毒素三嗪 - N - 氧化物衍生物的设计、合成及生物活性
Comp Biochem Physiol A Mol Integr Physiol. 2002 May;132(1):33-40. doi: 10.1016/s1095-6433(01)00526-8.
2
Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.抗血管生成性缺氧细胞毒素TX-402抑制缺氧诱导因子1信号通路。
Anticancer Res. 2003 Nov-Dec;23(6a):4427-34.
3
Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.1-甲基色氨酸-替拉扎明杂合物作为缺氧靶向吲哚胺2,3-双加氧酶抑制剂的合成及生物活性
Bioorg Med Chem. 2008 Sep 15;16(18):8661-9. doi: 10.1016/j.bmc.2008.07.087. Epub 2008 Aug 5.
4
Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.抗血管生成药物ZD6126与低氧细胞毒素治疗的联合应用,涉及对静止肿瘤细胞的影响以及肿瘤细胞对p53状态的依赖性。
Oncol Rep. 2005 Aug;14(2):393-400.
5
Design of hypoxia-targeting drugs as new cancer chemotherapeutics.作为新型癌症化疗药物的低氧靶向药物设计
Biol Pharm Bull. 2006 Dec;29(12):2335-42. doi: 10.1248/bpb.29.2335.
6
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.一种新型的缺氧依赖性2-硝基咪唑KIN-841通过阻断血管生成因子的产生来抑制肿瘤特异性血管生成。
Br J Cancer. 2003 Jan 27;88(2):307-13. doi: 10.1038/sj.bjc.6600667.
7
Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.抗血管生成性缺氧细胞放射增敏剂卤乙酰氨基甲酰基-2-硝基咪唑的设计、合成及生物活性
Bioorg Med Chem. 1997 Mar;5(3):591-9. doi: 10.1016/s0968-0896(96)00274-x.
8
Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.源自喹喔啉 1,4-二氧化物的低氧选择性剂。
J Med Chem. 1995 May 12;38(10):1786-92. doi: 10.1021/jm00010a023.
9
New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.新型喹喔啉 1,4 - 二氧化物。第1部分:源自喹喔啉 1,4 - 二氧化物的低氧选择性细胞毒素和抗癌剂。
Bioorg Med Chem. 2006 Oct 15;14(20):6917-23. doi: 10.1016/j.bmc.2006.06.038. Epub 2006 Jul 14.
10
Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.抗血管生成性缺氧细胞放射增敏剂的设计:含2-氨亚甲基-4-环戊烯-1,3-二酮部分的2-硝基咪唑类化合物
Bioorg Med Chem. 2008 Jun 1;16(11):6042-53. doi: 10.1016/j.bmc.2008.04.041. Epub 2008 Apr 24.

引用本文的文献

1
Synthesis and computational evaluation of the antioxidant activity of pyrrolo[2,3-]quinoxaline derivatives.吡咯并[2,3 - ]喹喔啉衍生物抗氧化活性的合成与计算评估
RSC Adv. 2024 Aug 5;14(34):24438-24446. doi: 10.1039/d4ra03108c.
2
The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.鸡胚绒毛尿囊膜作为一种研究抗血管生成的体内检测方法。
Pharmaceuticals (Basel). 2010 Mar 8;3(3):482-513. doi: 10.3390/ph3030482.
3
Synthesis, preferentially hypoxic apoptosis and anti-angiogenic activity of 1,2,4-benzotrazin-3-amine 1,4-dioxide bearing alkyl linkers with 1,2,4-benzotrazin-3-amine 1-oxide derivatives.
带有烷基连接基的1,2,4-苯并三嗪-3-胺1,4-二氧化物与1,2,4-苯并三嗪-3-胺1-氧化物衍生物的合成、优先低氧凋亡及抗血管生成活性
Anticancer Agents Med Chem. 2014;14(10):1428-46. doi: 10.2174/1871520614666141014130554.
4
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.替拉扎胺(TPZ)通过缺氧靶向作用诱导 Chk1/2 激活,从而优先抑制鼻咽癌细胞生长。
Invest New Drugs. 2011 Jun;29(3):401-10. doi: 10.1007/s10637-009-9356-z. Epub 2009 Dec 16.
5
Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.抗血管生成的每周低剂量环磷酰胺治疗期间肿瘤氧合和药物摄取增加,增强了每周一次的替拉扎明的抗肿瘤作用。
Curr Cancer Drug Targets. 2009 Sep;9(6):777-88. doi: 10.2174/156800909789271503.
6
Breast tumour angiogenesis.乳腺肿瘤血管生成
Breast Cancer Res. 2007;9(6):216. doi: 10.1186/bcr1796.
7
Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.硼中子俘获疗法中作为硼-10载体的缺氧特异性细胞毒性生物还原剂-硼硫代苹果酸酯-硼-10缀合物的评估
Radiat Med. 2006 Feb;24(2):98-107. doi: 10.1007/BF02493275.